PBE ETF holdings (NYSE) | MetaTrader

Open full chart

Overview All holdings Heatmap

Top holdings Market Value Shares Weight %

Invesco Private Prime Fund 36.34 M 36.34 M 12.89%

REGN Regeneron Pharmaceuticals, Inc. 15.43 M 20.23 K 5.47%

AMGN Amgen Inc. 14.72 M 38.22 K 5.22%

CDNA CareDx, Inc. 14.21 M 325.18 K 5.04%

VRTX Vertex Pharmaceuticals Inc. 14.06 M 29.46 K 4.99%

Invesco Private Government Fund 14.00 M 14.00 M 4.97%

RPRX Royalty Pharma PLC 13.93 M 238.42 K 4.94%

BIIB Biogen Inc. 13.50 M 66.51 K 4.79%

GILD Gilead Sciences, Inc. 12.50 M 96.03 K 4.43%

UTHR United Therapeutics Corp. 11.49 M 22.20 K 4.08%

TECH Bio-Techne Corp. 10.53 M 146.02 K 3.73%

ILMN Illumina, Inc. 9.89 M 48.23 K 3.51%

PTGX Protagonist Therapeutics, Inc. 9.57 M 70.05 K 3.40%

VCEL Vericel Corp. 9.21 M 200.30 K 3.27%

ALNY Alnylam Pharmaceuticals, Inc. 8.93 M 43.46 K 3.17%

INCY Incyte Corp. 8.62 M 72.14 K 3.06%

RGEN Repligen Corp. 8.57 M 60.81 K 3.04%

ACAD Acadia Pharmaceuticals Inc. 8.52 M 329.46 K 3.02%

HALO Halozyme Therapeutics, Inc. 8.41 M 101.93 K 2.98%

QGEN Qiagen N.V. 8.16 M 197.09 K 2.89%

1
2

News

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Market Concentration: Building For More Than One Outcome

Equity Outlook: AI, Higher Rates Raise The Bar For Diversification

Where Healthcare Innovation Meets Investment Opportunity

David Rubenstein Of The Carlyle Group On The Business Of Sports, Investing And Leadership

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

The Market May Be Telling Us We're Entering A Capital Formation Cycle

Where Is Growth?

The Investor Mentality

The Market Is Trying To Tell Us Something About 2027

Healthy And Energized At New Highs